Can 'Buy American’ Executive Order Shake Up ‘Dickensian’ Manufacturing Dynamics?
US OTC Industry Questions Imposing Change Amid 'Heat Of Global Pandemic'
Order sets a path for federal government to use its power as a purchaser of pharmaceuticals to nurture a high-tech domestic pharma manufacturing sector that would increase resilience against threats that could isolate the US from countries like China that are important nodes in the global manufacturing supply chain.
